These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 11173990)

  • 1. Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
    Ruan QR; Zhang WJ; Hufnagl P; Kaun C; Binder BR; Wojta J
    J Vasc Res; 2001; 38(1):13-9. PubMed ID: 11173990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on effect of anisodamine on expressions of tissue factor and plasminogen activator-1 inhibitor in vascular endothelial cells and its mechanisms].
    Ruan QR; Song JX; Deng ZD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 May; 24(5):422-6. PubMed ID: 15199627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anisodamine inhibits endotoxin-induced tissue factor expression in human endothelial cells.
    Ruan Q; Song J; Deng Z
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):273-5, 278. PubMed ID: 12674755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study on the mechanism of anisodamine against thrombosis].
    Ruan Q; Song J; Deng Z
    Zhonghua Bing Li Xue Za Zhi; 2000 Jun; 29(3):212-5. PubMed ID: 11866916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kappa B in TF induction by diverse agonists.
    Orthner CL; Rodgers GM; Fitzgerald LA
    Blood; 1995 Jul; 86(2):436-43. PubMed ID: 7605983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oligonucleotide decoy for nuclear factor-kappa B inhibits tumor necrosis factor-alpha-induced human umbilical cord vein endothelial cell tissue factor expression in vitro.
    Wang L; Wei W; Hu Y; Song S; Yan Z
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):483-90. PubMed ID: 15311157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of ligustrazini against thrombosis.
    Song J; Ruan Q
    Chin Med J (Engl); 2000 Feb; 113(2):136-9. PubMed ID: 11775537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation by nitric oxide of endotoxin-induced tissue factor and plasminogen activator inhibitor-1 in endothelial cells.
    Pérez-Ruiz A; Montes R; Velasco F; López-Pedrera C; Antonio Páramo J; Orbe J; Hermida J; Rocha E
    Thromb Haemost; 2002 Dec; 88(6):1060-5. PubMed ID: 12529760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivo.
    Zhang WJ; Wojta J; Binder BR
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):465-74. PubMed ID: 9102164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of PAI-1 expression by tumor necrosis factor alpha in endothelial cells is mediated by its responsive element located in the 4G/5G site.
    Swiatkowska M; Szemraj J; Cierniewski CS
    FEBS J; 2005 Nov; 272(22):5821-31. PubMed ID: 16279946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiparasitic treatment of patients with P. falciparum malaria reduces the ability of patient serum to induce tissue factor by decreasing NF-kappa B activation.
    Bierhaus A; Hemmer CJ; Mackman N; Kutob R; Ziegler R; Dietrich M; Nawroth PP
    Thromb Haemost; 1995 Jan; 73(1):39-48. PubMed ID: 7740494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligustrazini inhibits endotoxin induced PAI-1 expression in human umbilical vein endothelial cells.
    Ruan Q; Deng Z; Song J
    J Tongji Med Univ; 2001; 21(1):6-7, 16. PubMed ID: 11523251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF-alpha treated human umbilical vein endothelial cells.
    Zhou Z; Liu Y; Miao AD; Wang SQ
    J Cell Biochem; 2005 Sep; 96(1):109-16. PubMed ID: 16052513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells.
    Yoshizumi M; Tsuji H; Nishimura H; Masuda H; Kunieda Y; Kawano H; Kimura S; Sugano T; Kitamura H; Nakagawa K; Nakagawa M
    Thromb Haemost; 1999 Nov; 82(5):1497-503. PubMed ID: 10595644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.
    Kaneko T; Wada H; Wakita Y; Minamikawa K; Nakase T; Mori Y; Deguchi K; Shirakawa S
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):385-92. PubMed ID: 8075310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
    Hamaguchi E; Takamura T; Shimizu A; Nagai Y
    J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-kappaB, AP-1, and Sp1 activation.
    Hirata Y; Masuda Y; Kakutani H; Higuchi T; Takada K; Ito A; Nakagawa Y; Ishii H
    Biochem Pharmacol; 2008 Apr; 75(7):1504-14. PubMed ID: 18261712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa B.
    Pendurthi UR; Williams JT; Rao LV
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3406-13. PubMed ID: 9437186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
    Mussoni L; Banfi C; Sironi L; Arpaia M; Tremoli E
    Thromb Haemost; 2000 Jul; 84(1):59-64. PubMed ID: 10928471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.